
Opinion|Videos|October 22, 2024
68Gallium PSMA-11 PET-CT Imaging vs Conventional Imaging Techniques
Author(s)Oliver Sartor, MD
Key Takeaways
- Gallium PSMA-11 gozetotide is effective in detecting prostate cancer metastases and assessing biochemical recurrence with high sensitivity and specificity.
- The tracer is particularly useful for identifying small lesions and lymph node involvement in prostate cancer patients.
The panelist discusses how 68gallium prostate-specific membrane antigen-11 (PSMA-11) gozetotide is most useful in PET-CT imaging for detecting and staging prostate cancer.
Advertisement
In what situations would you use 68gallium prostate-specific membrane antigen-11 gozetotide in PET-CT imaging? In what situations would this tracer be less useful?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves enfortumab vedotin plus pembrolizumab for MIBC
2
The UroOnc Minute: AUA 2026 Update on Prostate Cancer Early Detection, With Badrinath R. Konety, MBBS
3
Amy E. Krambeck, MD, on choosing between CVAC and FANS for suction-based ureteroscopy
4
Trial launches of actinium (225Ac) rhPSMA-10.1 injection in mCRPC
5














